Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT06105554 · RECRUITING
Trial details
- NCT number
- NCT06105554
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-30
- Primary completion
- 2027-08-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.